SEARCH

SEARCH BY CITATION

References

  • 1
    Kamerbeek J, Schouls L, Kolk A et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907914.
  • 2
    Kotłowski R, Shamputa ICh, El Aila NA et al. PCR-based genotyping of Mycobacterium tuberculosis with new GC-rich repeated sequences and IS6110 inverted repeats used as primers. J Clin Microbiol 2004; 42: 372377.
  • 3
    Zwolska Z, Augustynowicz-Kopeć E, Klatt M. Primary and acquired drug resistance in Polish tuberculosis patients: results of a study of the national drug resistance surveillance programme. Int J Tuberc Lung Dis 2000; 4: 832838.
  • 4
    Van Embden JDA, Cave MD, Crawford JT et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406409.
  • 5
    Sajduda A, Brzostek A, Popławska M et al. Molecular epidemiology of drug-resistant Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Poland: a 1-year study. Int J Tuberc Lung Dis 2004; 8: 14481457.
  • 6
    Filliol I, Driscoll JR, Van Soolingen D et al. Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study. J Clin Microbiol 2003; 41: 19631970.
  • 7
    Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol 2002; 10: 4552.
  • 8
    Glynn JR, Whiteley J, Bifani PJ, Kremer K, Van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: 843849.
  • 9
    Krüüner A, Hoffner SE, Sillastu H et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 2001; 39: 33393345.
  • 10
    Toungoussova OS, Sandven P, Mariandyshev AO, Nizovtseva NI, Bjune G, Caugant DA. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol 2002; 40: 19301937.
  • 11
    Goguet de la Salmonière YO, Li HM, Torrea G, Bunschoten A, Van Embden JDA, Gicquel B. Evaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosis. J Clin Microbiol 1997; 35: 22102214.
  • 12
    Goyal M, Saunders NA, Van Embden JDA, Young DB, Shaw RJ. Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism. J Clin Microbiol 1997; 35: 647651.
  • 13
    Sola C, Horgen L, Maïsetti J, Devallois A, Goh KS, Rastogi N. Spoligotyping followed by double repetitive element PCR is a rapid alternative methodology to IS6110-fingerprinting for epidemiological studies of tuberculosis. J Clin Microbiol 1998; 36: 11221124.
  • 14
    Filliol I, Ferdinand S, Negroni L, Sola C, Rastogi N. Molecular typing of Mycobacterium tuberculosis based on variable number of tandem DNA repeats used alone and in association with spoligotyping. J Clin Microbiol 2000; 38: 25202524.
  • 15
    Sajduda A, Dziadek J, Kotłowski R, Portaels F. Evaluation of multiple genetic markers for typing drug-resistant Mycobacterium tuberculosis strains from Poland. Diagn Microbiol Infect Dis 2006; 55: 5964.
  • 16
    Augustynowicz-Kopeć E, Jagielski T, Kozińska M, Zabost A, Zwolska Z. The significance of spoligotyping method in epidemiological investigations of tuberculosis. Pneumonol Alergol Pol 2007; 75: 2231.
  • 17
    Braden CR, Templeton GL, Cave MD et al. Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis 1997; 175: 14461452.
  • 18
    Espinal MA, Laszlo A, Simonsen L et al. Global trends in resistance to antituberculosis drugs. World Health Organization—International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001; 344: 12941303.